Connect with us

Business

Pfizer raises 2021 COVID-19 vaccine sales forecast to $45.7 billion – ABC News

Drug manufacturer Pfizer is expected to gain $45.7 billion in sales this year as countries stock up on COVID-19 vaccines.

Published

on

Article feature image

Pfizer has raised its full-year sales forecast for the COVID-19 vaccine it developed with Germany’s BioNTech by 29 per cent to $US33.5 billion ($45.7 billion), as nations stock up on doses for the rest of the year.
Key points:

  • There’s been general positive…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending